Lucy Scientific Discovery Inc.
LSDI · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -138.3% | – | -358.6% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $2 | $2 | $2 |
| Operating Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | -8,906.5% | – | -29,799.1% | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$2 |
| Pre-Tax Income | -$1 | -$2 | -$3 | -$4 |
| Tax Expense | $2 | $0 | $0 | $1 |
| Net Income | -$3 | -$2 | -$3 | -$5 |
| % Margin | -29,028% | – | -36,565% | – |
| EPS | -0.16 | -0.11 | -0.15 | -0.39 |
| % Growth | -45.5% | 26.7% | 61.5% | – |
| EPS Diluted | -0.16 | -0.11 | -0.15 | -0.39 |
| Weighted Avg Shares Out | 18 | 18 | 17 | 14 |
| Weighted Avg Shares Out Dil | 18 | 18 | 17 | 14 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$2 | -$4 |
| % Margin | -11,937.9% | – | -30,466.2% | – |